WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009056671) METHOD FOR INHIBITING ANGIOGENESIS OR FOR TREATMENT OF CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/056671    International Application No.:    PCT/FI2008/050577
Publication Date: 07.05.2009 International Filing Date: 15.10.2008
IPC:
A61K 31/713 (2006.01), A61K 48/00 (2006.01), A61K 31/00 (2006.01), A61K 39/395 (2006.01), C12N 9/06 (2006.01), C12N 15/53 (2006.01), C12N 15/11 (2006.01), A61P 35/00 (2006.01)
Applicants: FARON VENTURES OY [FI/FI]; Tykistökatu 6 B FI-20520 Turku (FI) (For All Designated States Except US).
SALMI, Marko [FI/FI]; (FI) (For US Only).
JALKANEN, Sirpa [FI/FI]; (FI) (For US Only)
Inventors: SALMI, Marko; (FI).
JALKANEN, Sirpa; (FI)
Agent: ÖHMAN, Ann-Marie; Kaivokatu 15 B 23 FI-20520 Turku (FI)
Priority Data:
20070820 30.10.2007 FI
61/019,005 04.01.2008 US
Title (EN) METHOD FOR INHIBITING ANGIOGENESIS OR FOR TREATMENT OF CANCER
(FR) PROCÉDÉ POUR INHIBER L'ANGIOGENÈSE OU POUR TRAITER LE CANCER
Abstract: front page image
(EN)The invention concerns a method for inhibiting angiogenesis or for treating or preventing cancer or cancer metastasis in an individual. The method is based on the administration of an agent capable of counteracting the influence of or for down- regulating the expression of the vascular adhesion protein 1 (VAP-I). The inhibition of the catalytic activity of VAP-I is especially desirable for inhibiting angiogenesis and for treating or preventing of cancer or cancer metastasis.
(FR)L'invention porte sur un procédé pour inhiber l'angiogenèse ou pour traiter ou prévenir un cancer ou des métastases chez un individu. Le procédé repose sur l'administration d'un agent capable de contrebalancer ou de diminuer les effets de l'expression de la protéine d'adhésion vasculaire I (VAP-I). L'inhibition de l'activité catalytique de VAP-I est particulièrement souhaitable pour inhiber l'angiogenèse et pour traiter ou prévenir un cancer ou des métastases.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)